Denmark ditches J&J Covid-19 shots from vaccination programme

Hello and welcome to the details of Denmark ditches J&J Covid-19 shots from vaccination programme and now with the details

Nevin Al Sukari – Sana'a – Denmark is expected to exclude the Johnson & Johnson vaccine like it did the AstraZeneca vaccine. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


COPENHAGEN, May 3 — Denmark today became the first country to exclude Johnson & Johnson’s Covid-19 shots from its vaccination programme over a potential link to a rare but serious form of blood clot.

The move comes after the Nordic country last month stopped using AstraZeneca’s vaccine altogether citing similar concerns.

The country’s health authority said in a statement it had found that “the benefits of using the Covid-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine”.

Excluding the J&J vaccine, which accounts for around a third of Denmark’s total contracted supplies of Covid-19 shots, would delay the country’s vaccination calendar by up to four weeks, it said.

Denmark, which has so far fully vaccinated 11.5 per cent of its population, has gradually been reopening society since early March as infection rates has slowed, including indoor service at restaurants and cafes and allowing football fans into stadiums.

“Taking the present situation in Denmark into account, what we are currently losing in our effort to prevent severe illness from Covid-19 cannot outweigh the risk of causing possible side effects in the form of severe blood clots in those we vaccinate,” the health authority said.

It added that the vaccination rollout is progressing satisfactorily with other available vaccines.

Lawmakers at a meeting today agreed to allow voluntary use of the shots from both Johnson & Johnson and AstraZeneca, lawmaker Liselott Blixt of the Danish People’s Party told Reuters.

The rollout of J&J’s vaccine has also been delayed elsewhere in Europe over similar clotting concerns.

Europe’s drug regulator, the European Medicines Agency, said on April 20 it had found a possible link between J&J’s vaccine and rare blood clotting issues in adults who received doses in the United States.

But it backed the vaccine’s overall benefits against any risks. Since then, several European countries have resumed administering the vaccine.

EMA said its safety committee had concluded that a warning about unusual blood clots with low platelets must be added to the vaccine’s labels, just as was required of AstraZeneca. J&J said in a news release that it would comply with that measure. — Reuters

These were the details of the news Denmark ditches J&J Covid-19 shots from vaccination programme for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.